摘要 |
<p>The invention relates to a pharmaceutical preparation containing Clara cell protein CC10 or an active derivative thereof as active constituent, and a pharmaceutically acceptable carrier or diluent, and to Clara cell protein CC10 or an active derivative thereof for use as medicine, such as for use: i) in preventing tissue rejection after transplantation; ii) for treatment of infertility, septic shock, allergy, biliary cirrhosis, myasthenia gravis; or iii) to prevent premature birth, abortion by Gram-negative septicaemia, and for use as diagnostic. <IMAGE></p> |